Comparison of Five Antimicrobial Regimens for the Treatment of Brucellar Spondylitis: A Prospective, Randomized Study

REFERENCES

• Young EJ. Brucella species. In: Mandell GL, Bennet JE, Dolin R (eds). Principles and Practice of Infectious Diseases. Fifth ed. New York: Churchill Livingstone 2000: 2386-2393.
   Google Scholar
• Young EJ. An overview of human brucellosis. Clin Infect Dis 1995; 21: 283289.
   Web of Science ®Google Scholar
• Corbel MJ. Brucellosis: an Overview. Emerg Infect Dis 1997; 3 (2): 213–221.
   PubMed Web of Science ®Google Scholar
• Sonmez E, Durmaz B, Aladag M, Sahin K, Ozbilge H, Gunal S. Prevalence of brucellosis in Malatya Region. Turk J Med 1997; 2: 102–105.
   Google Scholar
• Durmaz R, Durmaz B, Refik M, Sonmez E. Seropositivity of brucellosis in Malatya, Turkey. Tr J Med Sci 1997; 27: 125–128.
   Google Scholar
• Sari R, Buyukberber N, Sevinc A, Bayindir Y, Buyukberber S. Brucellosis in the etiology of febrile neutrope-nia: case report. J Chemother 2002; 14: 88–91.
   PubMed Web of Science ®Google Scholar
• Sevinc A, Kutlu NO, Kuku I, Ozgen U, Aydogdu I, Soylu H. Severe epistaxis in brucellosis-induced isolated thrombocytopenia: a report of two cases. Clin Lab Haematol 2000; 22: 373–375.
   PubMedGoogle Scholar
• Colmenero JD, Reguera JM, Martos F, Sanchez-De-Mora D, Delgado M, Causse M, et al. Complications associat-ed with BruceIla melitensis infection: a study of 530 cases. Medicine 1996; 75 (4): 195–211.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Ibanez D, Garcia-Pais MJ. Osteoarticular complications of brucellosis in an Atlantic area of Spain. J Rheumatol 1999; 26: 141–145.
   PubMed Web of Science ®Google Scholar
• Lopez-Arlandis JM, Benedito J, Barcia Marino C, Hernandez M. Epidural spinal cord compression in brucellar spondylitis. Rev Clin Esp 1989; 185: 165–166.
   PubMed Web of Science ®Google Scholar
• Mousa AM, Bahar RH, Araj CF, Koshy TS, Muhtaseb SA, al-Mudallal DS, Marafie AA. Neurological complications of BruceIla spondylitis. Acta Neurol Scand 1990; 81: 16–23.
   PubMed Web of Science ®Google Scholar
• Sanchez-Gonzalez J, Garcia-Delange T, Martos F, Colmenero JD. Thrombosis of the abdominal aorta secondary to BruceIla spondylitis. Infection 1996; 24: 261–262.
   PubMed Web of Science ®Google Scholar
• Ariza J, Gudiol F, Valverde J, Pallares R, Fernandez-Viladrich P, Rufi G, et al. Brucellar spondylitis. A detailed analysis based on current findings. Rev Infect Dis 1985; 7: 656–664.
   Google Scholar
• Ariza J, Gudiol F, Pallares R, Viladrich PF, Rufi G, Corredoira J, Miravitlles MR. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus strepto-mycin: a randomized, double-blind study. Ann Intern Med 1992; 117: 25–30.
   PubMed Web of Science ®Google Scholar
• Al-Sibai MB, Halim MA, El-Shaker MM, Khan BA, Qadri SM. Efficacy of ciprofloxacin for treatment of BruceIla melitensis infections. Antimicrob Agents Chemother 1992; 36: 150–152.
   PubMed Web of Science ®Google Scholar
• Colmenero JD, Jimenez-Mejias ME, Sanchez-Lora FJ, Reguera JM, Palomino-Nicas J, Martos F, et al. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis 1997; 56: 709–715.
   PubMed Web of Science ®Google Scholar
• Solera J, Rodriguez-Zapata M, Geijo P, Largo J, Paulino J, Saez L, et al. Doxycycline-rifampin versus doxycy-cline-streptomycin in treatment of human brucellosis due to BruceIla melitensis. Antimicrob Agents Chemother 1995; 39: 2061–2067.
   PubMed Web of Science ®Google Scholar
• Tekkok IH, Berker M, Ozcan OE, Ozgen T, Akalin E. Brucellosis of the spine. Neurosurgery 1993; 33: 838–844.
   PubMed Web of Science ®Google Scholar
• Shapiro DS, Wong JD. Brucella. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (ed.). Manual of clin-ical microbiology, 7th ed. ASM Press, Washington DC, 1999, pp 625-631.
   Google Scholar
• Al-Shabed MS, Sharif HS, Haddad MC, Aabed MY, Sammak BM, Mutairi MA. Imaging features of musculoskeletal brucellosis. Radiographics 1994; 14: 333–348
   PubMed Web of Science ®Google Scholar
• Solomoon HM, Jackson D. Rapid diagnosis of BruceIla melitensis in blood; some operational characteristics of BACT/ ALERT. J Clin Microbiol 1992; 28: 2139–2141.
   Google Scholar
• Al Soub H, Uwaydah AK, Hussain AH. Vertebral osteomyelitis in Katar: Br J Clin Pract 1994; 48 (3): 130–132.
   PubMedGoogle Scholar
• Rajapakse CN. Bacterial infections: osteoarticular bru-cellosis. Clin Rheumatol 1995; 9 (1): 161–167.
   Web of Science ®Google Scholar
• Lopes C, Oliveira J, Malcata L, Pombo V, Da Cunha S, Corte-Real R, et al. Spinal brucellosis. 4 years of experi-ence. Acta Med Port 1992; 5: 419–423.
   PubMedGoogle Scholar
• Samra Y, Hertz M, Shaked Y, Zwas S, Altman G. Brucellosis of the spine: a report of 3 cases. J Bone Joint Surg Br 1982; 64: 429–431.
   PubMedGoogle Scholar
• Solera J, Lozano E, Martinez-Alfaro E, Espinosa A, Castillejos ML, Abad L. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis 1999; 29 (6): 1440–1449.
   PubMed Web of Science ®Google Scholar
• Hall WH. Modern chemotherapy for brucellosis in humans. Rev Infect Dis 1990; 12: 1060–1099.
   PubMedGoogle Scholar
• Food and Agriculture Organization: World Health Organization. FAO-WHO Expert Committee on Brucellosis. WHO Technical Report Series, 6th report, 1986; 740: 56-57.
   Google Scholar
• Colmenero Castillo JD, Hernandez Marquez S, Reguera Iglesias JM, Cabrera Franquelo F, Rius Diaz F, Alonso A. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. Chemotherapy 1989; 35 (2): 146–152.
   PubMed Web of Science ®Google Scholar
• Montejo JM, Alberola I, Glez-Zarate P, Alvarez A, Alonso J, Canovas A, et al. Open randomized therpeutic trial of six antimicrobial regimens in the treatment of human bru-cellosis. Clin Infect Dis 1993; 16 (5): 671–676.
   PubMed Web of Science ®Google Scholar
• Ariza J, Gudiol F, Pallares R, Rufi G, Fernandez-Viladrich P. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother 1985; 28 (4): 548–551.
   PubMed Web of Science ®Google Scholar
• Solera J, Martinez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drug 1997; 53: 245–256.
   PubMed Web of Science ®Google Scholar
• Lang R, Raz R, Sacks T, Shapiro M. Failure of pro-longed treatment with ciprofloxacin in acute brucellosis. J Antimicrobial Chemother 1990; 26: 841–846.
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez JA, Garcia Sanchez JE, Trujillano I. Lack of effective bactericidal activity of new quinolones against BruceIla spp. Antimicrob Agents Chemother 1991; 35: 756–759.
   PubMed Web of Science ®Google Scholar
• Kocagoz S, Akova M, Altun B, Cur D, Hascelik G. In vitro activities of new quinolones against BruceIla melitensis isolated in a tertiary-care hospital in Turkey. Clin Microbiol Infect 2002; 8: 240–242.
   PubMed Web of Science ®Google Scholar